Home » FDA Warns Biologic Manufacturer for Various GMP Deficiencies
FDA Warns Biologic Manufacturer for Various GMP Deficiencies
The FDA has issued a warning letter to Mexican biologics maker Instituto Bioclon for significant GMP deviations including failures to ensure adequate environmental monitoring and employee training.
Drug GMP Report
Drugs GMPs Inspections and Audits QualityDrug GMP Report
Upcoming Events
-
11Jul
-
18Jul
-
21Oct